✦ LIBER ✦

Evaluation of pandemic H1N1 (2009) influenza vaccine in adults with solid tumor and hematological malignancies on active systemic treatment

✍ Scribed by Helen J. Mackay; Jacob McGee; Diego Villa; Jonathan B. Gubbay; Lisa M. Tinker; Lily Shi; John Kuruvilla; Lisa Wang; Katrina MacAlpine; Amit M. Oza

Book ID: 116632015
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 212 KB
Volume: 50
Category: Article
ISSN: 1386-6532
DOI: 10.1016/j.jcv.2010.11.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pandemic whole-virion, Vero-cell-derived

Pandemic whole-virion, Vero-cell-derived, adjuvant-free influenza A H1N1 vaccine in patients with solid tumors and hematologic malignancies receiving concurrent anticancer treatment: Immunogenicity, tolerability, and acceptability during the pandemic situation

✍ Heimo Lagler; Selma Tobudic; Michael Ramharter; Katarzyna Elandt; Wolfgang R. Sp 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 706 KB

Impact of antiviral treatment and hospit

Impact of antiviral treatment and hospital admission delay on risk of death associated with 2009 A/H1N1 pandemic influenza in Mexico

✍ Gerardo Chowell, Cécile Viboud, Lone Simonsen, Mark A Miller, Santiago Echevarrí 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 228 KB

Immunogenicity and Safety of Varying Dos

Immunogenicity and Safety of Varying Dosages of a Monovalent 2009 H1N1 Influenza Vaccine Given With and Without AS03 Adjuvant System in Healthy Adults and Older Persons

✍ Jackson, L. A.; Chen, W. H.; Stapleton, J. T.; Dekker, C. L.; Wald, A.; Brady, R 📂 Article 📅 2012 🏛 University of Chicago Press 🌐 English ⚖ 221 KB

Immunogenicity and safety in adults of o

Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: Preliminary report of an observer-blind, randomised trial

✍ François Roman; Tejaswini Vaman; Beatrice Gerlach; Andre Markendorf; Paul Gillar 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 143 KB